Virginia-based Leidos, a digital and mission innovation company, recently announced it is investing $10 million over five years in collaboration with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) to accelerate the use of artificial intelligence (AI) for detecting and managing diseases.
Funding will be used to develop AI tools that can detect diseases more quickly to enable earlier, more effective care management and reduce diagnostic turnaround times.
“The University of Pittsburgh’s leadership in research and innovation, coupled with the expertise in technology solutions offered by Leidos, establishes a path forward to delivering advancements in diagnosis, disease management and health care delivery,” said Anantha Shekhar, University of Pittsburgh School of Medicine senior vice chancellor for the health sciences and John and Gertrude Petersen Dean.
The collaboration’s key objectives include developing the Digital Pathology Research Center and deploying AI-powered digital pathology solutions with the goal of leading the commercialization of innovative healthcare technologies.
The partners also hope their joint research projects will advance scanning technologies to analyze tissue samples and improve techniques for analyzing medical images with precision.
The partners also will create a workforce development and education initiative to cultivate the next generation of health care and AI innovators.